Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held N/A

William Ashton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 08 2024
SELL
Disposition due to a tender of shares in a change of control transaction
$209,002 $1.1 p/Share
190,002 Reduced 72.07%
73,620 Common Stock
Apr 08 2024
SELL
Sale (or disposition) back to the issuer
$80,982 $1.1 p/Share
73,620 Reduced 100.0%
0 Common Stock
Aug 28 2023
BUY
Open market or private purchase
$10,222 $0.46 p/Share
22,222 Added 7.77%
263,622 Common Stock
May 17 2023
BUY
Grant, award, or other acquisition
-
73,620 Added 23.37%
241,400 Common Stock
May 18 2022
BUY
Grant, award, or other acquisition
-
87,500 Added 34.28%
167,780 Common Stock
Apr 20 2021
BUY
Grant, award, or other acquisition
-
26,923 Added 25.11%
80,280 Common Stock

Also insider at

BXRX
Baudax Bio, Inc. Healthcare
SPPI
SPECTRUM PHARMACEUTICALS INC Healthcare
WA

William Ashton

Director
Boston, MA

Track Institutional and Insider Activities on REPH

Follow Societal CDMO, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REPH shares.

Notify only if

Insider Trading

Get notified when an Societal Cdmo, Inc. insider buys or sells REPH shares.

Notify only if

News

Receive news related to Societal CDMO, Inc.

Track Activities on REPH